The short answer.
Sublocade and Suboxone both use buprenorphine to treat opioid use disorder.
The difference is how the medication is given.
Suboxone is taken regularly by mouth.
Sublocade is a monthly injection given after treatment has already started.
What they have in common
The same underlying medication.
Both medications are used to treat opioid use disorder. Both reduce withdrawal symptoms and cravings. Both are based on buprenorphine.
The choice is not about one being stronger or better in a simple way. It is about which form makes sense for a given patient at a given point in treatment.
Suboxone
Taken regularly, adjusted as needed.
Suboxone is buprenorphine combined with naloxone. It is usually taken as a film or tablet that dissolves under the tongue.
Because it is taken regularly, the dose can be adjusted more easily early in treatment. For many patients, Suboxone is how treatment starts.
Sublocade
A monthly injection.
Sublocade is an extended-release buprenorphine injection given once a month. Instead of taking medication daily, the medication is released gradually over time after the injection.
Sublocade is generally used after a patient has already started buprenorphine treatment and has stabilized on it.
Sublocade is administered only by a healthcare provider in a certified setting under a Risk Evaluation and Mitigation Strategy (REMS) program. It is not self-administered. Sublocade carries a boxed warning: intravenous self-injection of the depot can cause serious harm or death.
How the choice is made
It depends on where you are in treatment.
These factors typically come into the decision:
whether treatment is just beginning
whether dose adjustments are still needed
whether daily medication is working well
whether a monthly injection would make treatment simpler
Some patients prefer the flexibility of a daily medication. Others prefer the consistency of a monthly injection.
Starting treatment
Suboxone is more commonly used at the start.
Beginning buprenorphine treatment often requires attention to timing, dose, and response in the first days and weeks. Suboxone allows for those adjustments.
Once treatment is established and stable, Sublocade may become an option.
Ongoing care
Both still require medical follow-up.
The difference is not whether care is needed. It is how the medication is delivered within that care.
Treatment decisions are made over time, based on response, stability, and what is clinically appropriate.
In practice
Often part of the same pathway.
Suboxone and Sublocade are not competing treatments in a simple sense. Often, they are part of the same treatment pathway:
Suboxone to start.
Sublocade later, if it makes sense.
That decision is individual.
Stopping Sublocade
The medication has a long tail.
After the last Sublocade injection, buprenorphine continues to release from the depot for months. Detectable levels can persist for 6–12 months or longer in some patients. This means that decisions about stopping or transitioning Sublocade should be discussed with your physician in advance — there is no quick way to remove the medication once injected.
Related